Rajeev M. Shah, Director at Artiva Biotherapeutics, bought ARTV on Jul 10, 2026
Data as of Oct 16
- Traded
- Jul 10, 2026
- Disclosed
- Jul 14, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ARTV since disclosure
−37.4%
Similar stocks (XLV) since disclosure
+11.6%
XLV — its sector index fund
Change in closing price from Jul 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$58.6Kdisclosed Jul 14 · filed 1 day after the trade
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$58.6Kdisclosed Jul 14 · filed 1 day after the trade
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$58.6Kdisclosed Jul 14 · filed 1 day after the trade
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$58.6Kdisclosed Jul 14 · filed 1 day after the trade
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$58.6Kdisclosed Jul 14 · filed 1 day after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$58.6Kdisclosed Jul 14 · filed 1 day after the trade
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$135Kdisclosed Jul 14 · filed 4 days after the trade
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$135Kdisclosed Jul 14 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$135Kdisclosed Jul 14 · filed 4 days after the trade
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$135Kdisclosed Jul 14 · filed 4 days after the trade
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$135Kdisclosed Jul 14 · filed 4 days after the trade